Friday, 20 Jul 2018

You are here

Pharma Pays $8.2 Billion to Physicians in 2016

Data made public by the Centers for Medicare & Medicaid Services shows that drug and device makers made nearly $8.2 billion in payments to U.S. physicians and teaching hospitals in the last year. Since 2013, CMS has been tracking physician payments as part of the Affordable Care Act.

While research expenditures ($4.36 billion) made up more than half of this amount, the remainder includes funds distributed to cover expenses like travel, gifts, speaking fees and meals ($2.8 billion in "general payments"). 

The top three payouts came from Roche ($586 million), Novartis and Pfizer ($475 million each). Novartis, Pfizer and AstraZeneca spent the most on research payments ($450 million, $430 million, $367 million, respectively).

The detailed data also highlights the complexity of multinational drug companies' corporate structures. Pfizer, for instance, reported payments made through 14 different corporate entities. J&J and Roche each had more than ten reporting bodies, if the wholly owned subsidiaries of Janssen and Genentech, respectively, are included. 

For more info on open payments or payments made to individual physicians go to: https://openpaymentsdata.cms.gov/summary.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

While these numbers are somewhat alarming and reflect speaker fees, consultant fees and meals, I wonder if they also include payment for services performed in clinical trials. Physicians work hard in clinical research and deserve fair reimbursement. I am aware that early on the Sunshine Act inappropriately posted these numbers. Of course payments often go to salary for study coordinators, IRB, etc and do not end up entirely in the physicians pocket book.

More Like This

The RheumNow Week in Review – Cocoon Therapy? (7.20.18)

Dr. Jack Cush reviews highlights from the news and social media on RheumNow.com in the past week. 

Proposed Changes for 2019 Medicare Fee Schedule

On July 12th the Centers for Medicare & Medicaid Services (CMS) released its proposed rule changes for the 2019 Medicare physician fee schedule.  This year, CMS has combined the Medicare physician fee schedule proposed rule with recommendations for the Quality Payment Program (QPP), which will be officially published in the Federal Register on July 27.

Trend Towards Fewer Self-Employed Physicians

 

A nationwide survey study analyzed healthcare provider (HCP) employment type (self-employed, employed by private sector, or employed by government) and annual labor earnings (2001 to 2015) and found that the health care landscape is changing with few self-employed practitioners and more being larger organizations. 

The RheumNow Week in Review –Fateful Outcomes in Rheumatology (7.13.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  Fateful outcomes in Rheumatology, what happens to Seronegatives, IL-23 fails, MRI progression, Not all inflammatory back pain becomes SpA:

The RheumNow Week in Review – Life Savers for Rheumatologists (6.29.18)

Dr. Jack Cush reviews selected news and journal reports from the past week on RheumNow.com.